Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies
Hereditary angioedema (HAE) caused by C1-esterase inhibitor deficiency is an autosomal-dominant disease resulting from a mutation in the C1-inhibitor gene. HAE is characterized by recurrent attacks of intense, massive, localized subcutaneous edema involving the extremities, genitalia, face, or trunk...
Main Authors: | Richard G Gower, MD, Paula J Busse, MD, Emel Aygören-Pürsün, MD, Amin J Barakat, MD, Teresa Caballero, MD, Mark Davis-Lorton, MD, Henriette Farkas, MD, David S Hurewitz, MD, Joshua S Jacobs, MD, Douglas T Johnston, MD, William Lumry, MD, Marcus Maurer, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119304533 |
Similar Items
-
WAO Guideline for the Management of Hereditary Angioedema
by: Timothy Craig, DO, et al.
Published: (2012-01-01) -
Efficacy and Safety of an Intravenous C1-Inhibitor Concentrate for Long-Term Prophylaxis in Hereditary angioedema
by: Timothy Craig D.O., et al.
Published: (2017-03-01) -
Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema
by: Inmaculada Martinez-Saguer, MD, PhD, et al.
Published: (2024-02-01) -
The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
by: Marcus Maurer, MD, et al.
Published: (2022-03-01) -
Throat microbiota alterations in patients with hereditary angioedema
by: Xue Wang, MD, et al.
Published: (2022-10-01)